Hillsdale Investment Management Inc. Has $182,000 Stock Holdings in Cognyte Software Ltd. (NASDAQ:CGNT)

Hillsdale Investment Management Inc. increased its position in shares of Cognyte Software Ltd. (NASDAQ:CGNT) by 32.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,339 shares of the medical device company’s stock after acquiring an additional 7,000 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Cognyte Software were worth $182,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. New York State Common Retirement Fund lifted its stake in Cognyte Software by 662.4% in the third quarter. New York State Common Retirement Fund now owns 45,065 shares of the medical device company’s stock valued at $217,000 after buying an additional 39,154 shares during the period. Quantbot Technologies LP acquired a new position in Cognyte Software in the third quarter valued at about $57,000. Citigroup Inc. lifted its stake in Cognyte Software by 3.0% in the third quarter. Citigroup Inc. now owns 138,749 shares of the medical device company’s stock valued at $667,000 after buying an additional 3,993 shares during the period. Phoenix Holdings Ltd. lifted its stake in Cognyte Software by 33.0% in the third quarter. Phoenix Holdings Ltd. now owns 279,400 shares of the medical device company’s stock valued at $1,344,000 after buying an additional 69,400 shares during the period. Finally, Acadian Asset Management LLC lifted its stake in Cognyte Software by 203.6% in the third quarter. Acadian Asset Management LLC now owns 1,578,537 shares of the medical device company’s stock valued at $7,577,000 after buying an additional 1,058,675 shares during the period. Institutional investors and hedge funds own 72.92% of the company’s stock.

Cognyte Software Trading Down 2.0 %

NASDAQ:CGNT opened at $7.53 on Wednesday. Cognyte Software Ltd. has a 52-week low of $4.00 and a 52-week high of $8.53. The stock has a 50-day simple moving average of $7.47 and a 200 day simple moving average of $6.65.

Cognyte Software (NASDAQ:CGNT) last posted its quarterly earnings data on Tuesday, April 9th. The medical device company reported ($0.28) earnings per share (EPS) for the quarter. The firm had revenue of $83.69 million for the quarter. Cognyte Software had a negative return on equity of 12.06% and a negative net margin of 4.97%. As a group, analysts forecast that Cognyte Software Ltd. will post -0.3 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on CGNT shares. Evercore ISI increased their target price on Cognyte Software from $5.00 to $7.50 and gave the company an “in-line” rating in a research note on Wednesday, April 10th. StockNews.com upgraded Cognyte Software from a “buy” rating to a “strong-buy” rating in a report on Wednesday, April 10th. Wedbush increased their price target on Cognyte Software from $5.00 to $8.00 and gave the stock a “neutral” rating in a report on Thursday, April 11th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cognyte Software in a report on Friday, May 17th.

About Cognyte Software

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company offers network intelligence analytics, threat intelligence analytics, decision intelligence analytics, and operational intelligence analytics solutions.